Glucotrack, Inc. (GCTK) Form 8-K — Oct 29, 2026

Glucotrack (GCTK) received written notice on October 28, 2026 that a Nasdaq Hearings Panel determined to delist its securities after the company's closing bid price fell to $0.87 on October 14, 2026, breaching the terms of its compliance exception. Trading in GCTK common stock on Nasdaq will be suspended at the open of trading on October 30, 2026, and Nasdaq is expected to file a Form 25 to delist and deregister the shares under Section 12(b).

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.